{"entity":{"id":"nct06641635","kind":"trial","name":"Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer","aka":[],"tldr":"A phase 3 trial of Adaptive radiotherapy in Cervical cancer, run by Peking Union Medical College Hospital, now recruiting.","summary":"Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer is a phase 3 interventional study registered as NCT06641635 by Peking Union Medical College Hospital, with 440 participants planned, started 2024-11-19 and due to reach its primary completion in 2026-10-31. Interventions recorded: Moderated hypofractionated online adaptive radiotherapy, Conventional radiotherapy. Conditions recorded: Cervical Cancer, Adaptive Radiotherapy.\n\nLinked to the technology Adaptive radiotherapy because the registry names it (\"adaptive radiotherapy\") among its interventions and Cervical cancer among its conditions. Registry record only: no result has been read by an editor.","status":"recruiting","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT06641635","url":"https://clinicaltrials.gov/study/NCT06641635"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["cervical"],"sections":[],"technologies":["adaptive-radiotherapy"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06641635","phase":"3","setting":"A Multicenter, Non-inferiority, Phase 3, Randomized Controlled Study of Moderated Hypofractionated Online Adaptive Radiotherapy for Cervical Cancer","sponsor":"Peking Union Medical College Hospital","enrolled":440,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06641635/","neighbours":{"cancer":[{"id":"cervical","kind":"cancer","name":"Cervical cancer","route":"/cancers/cervical/"}],"technology":[{"id":"adaptive-radiotherapy","kind":"technology","name":"Adaptive radiotherapy (online replanning)","route":"/technologies/adaptive-radiotherapy/"}]}}